ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0463 • ACR Convergence 2020

    Molecular Diagnosis of Childhood Immunodysregulation, Endocrinopathy and Enteropathy X-linked (IPEX)-Like Syndrome and Implications for Clinical Management

    Sarah Baxter1, Tom Walsh1, Silvia Casadei1, Suleyman Gulsuner1, Eric Allenspach2, David Hagin3, Gesmar Segundo4, Troy Torgerson5 and Mary-Claire King1, 1University of Washington, Seattle, 2Seattle Children's Research Institute, Seattle, 3Tel Aviv Medical Center, Tel Aviv, Israel, 4Universidade Federal de Uberlandia, Uberlandia, Brazil, 5Allen Institute, Seattle

    Background/Purpose: Patients with early-onset immunodysregulation, endocrinopathy and enteropathy but without identified mutations in FOXP3 are termed “IPEX-like,” and undergo trial-and-error immunosuppressive treatment with highly variable…
  • Abstract Number: 0458 • ACR Convergence 2020

    Rapid Implementation of a Multidisciplinary COVID-19 Cytokine Storm Syndrome Task Force

    Bibi Ayesha1, Anand Kumthekar1, Ruchi Jain2, Sneha Patel3, Manish Ramesh1, Denisa Ferastraoaru4, Golda Hudes4, Merhunisa Karagic4, Sheema Zafar1, Rachel Bartash4, Natalia Vasquez-Canizares5, Elizabeth Kitsis6, Clement Tagoe7, Dawn Wahezi5, Tamar Rubinstein8 and Anna Broder3, 1Montefiore Medical Center, Bronx, NY, 2Montefiore Medical Center, Irvington, NY, 3Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, 4Montefiore Medical Center, Bronx, 5Albert Einstein College of Medicine, Bronx, NY, 6Albert Einstein College of Medicine, New York, NY, 7Albert Einstein College of Medicine, Fresh Meadows, NY, 8Albert Einstein College of Medicine / Montefiore Medical Center, White Plains, NY

    Background/Purpose: Coronavirus disease (COVID-19) infected patients present with a state of ongoing inflammation and an exaggerated inflammatory state due to unregulated cytokine release called the…
  • Abstract Number: 0472 • ACR Convergence 2020

    ApoB:ApoA1 Ratio Could Predict Atherosclerotic Risk in Juvenile-SLE Patients Associated with Altered Interferon Signalling in CD8+ T-cells

    George Robinson1, Kirsty Waddington2, Leda Coelewij2, Junjie Peng2, Meena Naja2, Chris Wincup2, Anna Radziszewska2, Hannah Peckham2, David Isenberg2, Yiannis Ioannou2, Ines Pineda Torra2, Coziana Ciurtin2 and Elizabeth Jury2, 1University College London, Hertford, United Kingdom, 2University College London, London, United Kingdom

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease characterised by immune-dysregulation, chronic inflammation, type-I interferon (IFN) signatures and increased cardiovascular disease (CVD) risk…
  • Abstract Number: 0471 • ACR Convergence 2020

    Splice Site Variants in IKBKG, Encoding NEMO, Detected by a Customized Analysis of Next-Generation Sequencing Data Cause an Early-onset Autoinflammatory Syndrome of Panniculitis and Cytopenias in Male and Female Patients

    Adriana de Jesus1, Sofia Torreggiani2, Bin Lin2, Jacob Mitchell2, Eric Karlins3, Andrew Oler3, Sara Alehashemi4, Dana Kahle5, Katelin R. Honer2, Gema Souto Adeva2, Eric Hanson6, Gina Montealegre Sanchez7, Amer Khojah8, Timothy Moran9, Eveline Wu9, Chris Scott10, Timothy Ronan Leahy11, Emma Jane MacDermott11, Orla Killeen12, Thaschawee Arkachaisri13, Zoran Gucev14, Kathryn Phillippi15, Vafa Mammadova16, Gulnara Nasrullayeva16 and Raphaela Goldbach-Mansky17, 1Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Silver Spring, MD, 2Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Bethesda, MD, 3Bioinformatics and Computational Biosciences Branch/NIAID/NIH, Bethesda, MD, 4Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Clarksville, MD, 5Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Bethesda, 6Indiana University School of Medicine, Indianapolis, IN, 7NIAID/NIH, Rockville, MD, 8Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 9UNC Chapel Hill, Chapel Hill, NC, 10University of Cape Town, Cape Town, South Africa, 11Our Lady's Children's Hospital, Dublin, Ireland, 12National Centre for Paediatric Rheumatology, CHI at Crumlin, Dublin, Ireland, 13Duke-NUS Medical School, Singapore, Singapore, 14University Children's Hospital, Medical Faculty Skopje, Skopje, Macedonia, 15Akron Children’s Hospital, Akron, OH, 16Azerbaijan Medical University, Baku, Azerbaijan, 17Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Potomac, MD

    Background/Purpose: The Inhibitor of Kappa-B Kinase Regulatory Subunit Gamma (IKBKG) is located on the X chromosome and encodes the NF-κB essential modulator (NEMO). Loss-of-function mutations…
  • Abstract Number: 0477 • ACR Convergence 2020

    Rheumatology Fellowship Program Directors in the United States: Analysis of Demographics, Educational and Scholarly Achievements

    Aakanksha Khanna1, Dawid Czarny2, Vibhor Wadhwa3 and Alysia Kwiatkowski4, 1Department of Medicine, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, 2University at Buffalo, Amherst, NY, 3Department of Radiology, University of Arkansas for Medical Sciences, Little Rock, AR, 4State University of New York at Buffalo, Clarence, NY

    Background/Purpose: Rheumatology program directors (PDs) play a vital role in developing, improving and overseeing the fellowship programs. Although PDs have an important role to play…
  • Abstract Number: 0476 • ACR Convergence 2020

    Using Consensus Building to Guide Rheumatology Curriculum Development for Internal Medicine Residents

    Sarah Goglin1 and Jennifer Babik2, 1University of California San Francisco, Burlingame, CA, 2University of California San Francisco, San Francisco, CA

    Background/Purpose: In spite of the increasing burden of rheumatic diseases in the United States, many patients have limited access to rheumatologists. As a result, internists…
  • Abstract Number: 0482 • ACR Convergence 2020

    Differential Influence of CDAI Components Based on Disease State in Rheumatoid Arthritis Patients: Real World Results from a Rheumatoid Arthritis Cohort

    Edward C Keystone1, Mohammad Movahedi2, Angela Cesta3, Claire Bombardier4, John Sampalis5 and Emmanouil Rampakakis5, 1Mount Sinai Hospital, Toronto, ON, Canada, 2Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 3Toronto General Hospital Research Institute, Toronto, ON, Canada, 4Institute for Work and Health, Toronto, ON, Canada, 5JSS Medical Research, St-Laurent, QC, Canada

    Background/Purpose: Treat-to-target recommendations for rheumatoid arthritis (RA) dictate that remission or low disease activity should be aimed. Although numerous composite indices are available, the clinical…
  • Abstract Number: 0484 • ACR Convergence 2020

    Relationship Between Paraoxonase-1 Genotype, Activity, and Major Adverse Cardiovascular Events in Patients with Rheumatoid Arthritis Receiving Tofacitinib

    Christina Charles-Schoeman1, Craig Hyde2, Shunjie Guan3, Neil Parikh1, Jennifer Wang1, Ani Shahbazian1, Lori Stockert4 and John Andrews4, 1University of California, Los Angeles, Los Angeles, CA, 2Pfizer Inc, Groton, CT, 3Pfizer Inc, Cambridge, MA, 4Pfizer Inc, Collegeville, PA

    Background/Purpose: Paraoxonase 1 (PON1) is a high-density lipoprotein (HDL)‑associated enzyme with paraoxonase, lactonase, and arylesterase activities. PON1 contributes to the antioxidant properties of HDL, and…
  • Abstract Number: 0479 • ACR Convergence 2020

    Early DAS Response After DMARD-start Increases Probability of Achieving Sustained DMARD-free Remission in Rheumatoid Arthritis

    Marloes Verstappen1, Ellis Niemantsverdriet2, Xanthe Matthijssen2, Saskia le Cessie2 and Annette van der Helm - van Mil3, 1Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Leiden University Medical Center, Erasmus Medical Center, Leiden, Netherlands

    Background/Purpose: Sustained DMARD-free remission (SDFR) is increasingly achievable. The pathogenesis underlying SDFR-development is unknown and patient-characteristics at diagnosis poorly explain whether SDFR will be achieved.…
  • Abstract Number: 0474 • ACR Convergence 2020

    Assessment of Teaching Behavior and Knowledge Among Faculty to Inform an Active Teaching Intervention Within a Rheumatology Fellowship Curriculum

    Stefanie Wade1, Vasileios Kyttaris1, Jason Freed2 and Jonathan Hausmann3, 1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MA, 3Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA

    Background/Purpose: The science of learning has provided us with evidence-based tools to enhance learning.  Studies show that greater learning occurs in interactive workshops that tackle…
  • Abstract Number: 0487 • ACR Convergence 2020

    Association Between an Extended Lifestyle Score and Adverse Health-related Outcomes in People with Rheumatoid Arthritis: A Study of 5295 UK Biobank Participants

    Jordan Canning1, Stefan Siebert2, Bhautesh Jani1, Frances Mair1 and Barbara Nicholl1, 1University of Glasgow, Glasgow, Scotland, United Kingdom, 2University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterised by inflammation of the synovial joints. Traditional lifestyle factors, such as smoking and poor diet,…
  • Abstract Number: 0490 • ACR Convergence 2020

    Fine Specificity Anti-Citrullinated Protein Antibodies as Biomarkers for Prediction of Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease

    Vanessa Kronzer1, Weixing Huang2, Paul Dellaripa3, Sicong Huang4, Vivi Feathers2, Bing Lu5, Christine Iannaccone4, Ritu Gill6, Hiroto Hatabu7, Mizuki Nishino7, Cynthia Crowson8, John Davis1, William Robinson9, Tripta Rughwani9, Jeremy Sokolove10, Michael Weinblatt4, Nancy Shadick11, Tracy J. Doyle12 and Jeffrey Sparks11, 1Mayo Clinic, Rochester, MN, 2Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, 3Division of Rheumatology, Brigham and Women's Hospital, Boston, Massachusetts, USA, Boston, MA, 4Brigham and Women's Hospital, Boston, MA, 5Brigham and Women's Hospital and Harvard Medical School, Newton, MA, 6Beth Israel Deaconess Medical Center, Boston, MA, 7Department of Radiology; Brigham and Women’s Hospital, Boston, 8Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN, 9Stanford University, Palo Alto, CA, 10Stanford University, Mountain View, CA, 11Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 12Brigham and Women's Hospital, West Roxbury, MA

    Background/Purpose: Seropositivity for anti-citrullinated protein antibodies (ACPA) has been shown to increase risk for RA-associated interstitial lung disease (RA-ILD). However, RA-related autoantibodies used in clinical…
  • Abstract Number: 0491 • ACR Convergence 2020

    Relationship Between Rheumatoid Arthritis and Pulmonary Function in the UK Biobank

    Lauren C. Prisco1, Matthew Moll1, Jiaqi Wang2, Weixing Huang3, Lily Martin1, Vanessa Kronzer4, Sicong Huang2, Edwin Silverman2, Tracy J. Doyle5, Michael Cho5 and Jeffrey Sparks6, 1Brigham and Women's Hospital, Boston, 2Brigham and Women's Hospital, Boston, MA, 3Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, 4Mayo Clinic, Rochester, MN, 5Brigham and Women's Hospital, West Roxbury, MA, 6Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Established pulmonary manifestations of RA include restrictive processes such as interstitial lung disease and obstructive processes such as bronchiectasis, but clinically detected forms of…
  • Abstract Number: 0486 • ACR Convergence 2020

    Differences in Low-density Lipoprotein (LDL) Particle Composition and Oxidation May Underlie the Paradoxical Association of Low LDL with Higher Coronary Atherosclerosis Burden in Rheumatoid Arthritis

    George Karpouzas1, Sarah Ormseth1, Elizabeth Hernandez1 and Matthew Budoff1, 1Harbor-UCLA Medical Center and the Lundquist Institute, Torrance, CA

    Background/Purpose: Rheumatoid arthritis (RA) patients in the lowest LDL group (< 70mg/dl) experience unexpectedly high cardiovascular risk. We first explored whether this group (Group 1)…
  • Abstract Number: 0494 • ACR Convergence 2020

    Genetic-epigenetic Interaction and the Relationship Between DNA Methylation Patterns and Disease Activity in a Longitudinal Cohort of Lupus Patients

    Patrick Coit1, Lourdes Ortiz-Fernandez2, Emily Lewis3, W. Joseph McCune3, Kathleen Maksimowicz-McKinnon4 and Amr Sawalha2, 1University of Pittsburgh and University of Michigan, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA, 3University of Michigan, Ann Arbor, MI, 4Henry Ford Hospital, Detroit

    Background/Purpose: Genetic factors and epigenetic dysregulation are implicated in the pathogenesis of lupus. We performed a longitudinal analysis of DNA methylation in lupus patients for…
  • « Previous Page
  • 1
  • …
  • 657
  • 658
  • 659
  • 660
  • 661
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology